Related Experiment Videos

[Coronary disease in patient following heart transplantation]

C Benvenuti1, A Nitenberg, E Aptecar

  • 1Service de chirurgie cardiaque, hôpital Henri Mondor, Créteil.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|February 1, 1991
PubMed

Insights

Coronary artery disease is a severe complication after cardiac transplantation, often silent due to denervation. Early diagnosis and understanding its multifactorial causes are crucial for managing graft dysfunction and improving patient outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Vascular Biology

Background:

  • Coronary artery disease (CAD) is a severe complication following cardiac transplantation, leading to graft destruction via ischemia.
  • Cardiac denervation often renders CAD asymptomatic, with cardiac failure, infarction, or sudden death as sole indicators.
  • Prevalence of coronary lesions reaches 25% at 2 years and 50% at 5 years post-transplant.

Purpose of the Study:

  • To review the characteristics, diagnosis, pathogenesis, and management of coronary artery disease in cardiac transplant recipients.
  • To highlight the challenges in diagnosing and preventing this complication.

Main Methods:

  • Review of literature on coronary artery disease in cardiac transplant recipients.
  • Analysis of epidemiological data, lesion morphology, and histological features.
  • Discussion of diagnostic challenges and potential pathogenetic factors.

Main Results:

  • Coronary lesions are diffuse, concentric, occlusive, and predominantly distal, lacking collateral circulation.
  • Histology may show medial necrosis, endothelial damage, and inflammation, suggestive of arteriolitis, often linked to rejection.
  • No non-invasive diagnostic method is sufficiently sensitive, leading to routine annual coronary angiography in many centers.

Conclusions:

  • The pathogenesis of transplant-associated CAD is multifactorial, involving lipid metabolism, immunology, and Cytomegalovirus infection.
  • Lack of identifiable risk factors complicates prevention strategies.
  • Retransplantation is considered for selected patients to mitigate acute coronary events and sudden death risk.

Related Concept Videos